These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32220937)

  • 21. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.
    Palagyi A; Keay L; Harper J; Potter J; Lindley RI
    BMC Geriatr; 2016 Jan; 16():15. PubMed ID: 26767619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "… Above All, It's a Matter of  This Person's Quality of Life": Health Care Professionals' Perspectives on Deprescribing in Older Patients With Limited Life Expectancy.
    Lundby C; Graabæk T; Ryg J; Søndergaard J; Pottegård A; Nielsen DS
    Gerontologist; 2020 Apr; 60(3):439-449. PubMed ID: 31433836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A deprescribing medication program to evaluate falls in older adults: methods for a randomized pragmatic clinical trial.
    Niznik J; Ferreri SP; Armistead L; Urick B; Vest MH; Zhao L; Hughes T; McBride JM; Busby-Whitehead J
    Trials; 2022 Apr; 23(1):256. PubMed ID: 35379307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploration of GP perspectives on deprescribing antidepressants: a qualitative study.
    Kelly D; Graffi J; Noonan M; Green P; McFarland J; Hayes P; Glynn L
    BMJ Open; 2021 Apr; 11(4):e046054. PubMed ID: 33820792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacist interventions to deprescribe opioids and benzodiazepines in older adults: A rapid review.
    Niznik JD; Collins BJ; Armistead LT; Larson CK; Kelley CJ; Hughes TD; Sanders KA; Carlson R; Ferreri SP
    Res Social Adm Pharm; 2022 Jun; 18(6):2913-2921. PubMed ID: 34281786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid deprescribing in patients with chronic noncancer pain: a systematic review of international guidelines.
    Hamilton M; Kwok WS; Hsu A; Mathieson S; Gnjidic D; Deyo R; Ballantyne J; Von Korff M; Blyth F; Lin CC
    Pain; 2023 Mar; 164(3):485-493. PubMed ID: 36001299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barriers and enablers to deprescribing in long-term care: A qualitative investigation into the opinions of healthcare professionals in Ireland.
    Heinrich CH; McHugh S; McCarthy S; Donovan MD
    PLoS One; 2022; 17(12):e0274552. PubMed ID: 36520798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a hospital deprescribing implementation framework: A focus group study with geriatricians and pharmacists.
    Scott S; Twigg MJ; Clark A; Farrow C; May H; Patel M; Taylor J; Wright DJ; Bhattacharya D
    Age Ageing; 2019 Dec; 49(1):102-110. PubMed ID: 31711097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals.
    Turner JP; Edwards S; Stanners M; Shakib S; Bell JS
    BMJ Open; 2016 Mar; 6(3):e009781. PubMed ID: 26966056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges and opportunities in creating a deprescribing program in the emergency department: A qualitative study.
    Lee S; Bobb Swanson M; Fillman A; Carnahan RM; Seaman AT; Reisinger HS
    J Am Geriatr Soc; 2023 Jan; 71(1):62-76. PubMed ID: 36258309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: protocol for a qualitative evidence synthesis using the Theoretical Domains Framework.
    Cross AJ; Buchbinder R; Bourne A; Maher C; Mathieson S; Lin CC; O'Connor DA
    BMJ Open; 2019 Nov; 9(11):e034039. PubMed ID: 31722956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the behavioural determinants of opioid prescribing among family physicians: a qualitative study.
    Desveaux L; Saragosa M; Kithulegoda N; Ivers NM
    BMC Fam Pract; 2019 May; 20(1):59. PubMed ID: 31077137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploration of home care nurse's experiences in deprescribing of medications: a qualitative descriptive study.
    Sun W; Tahsin F; Barakat-Haddad C; Turner JP; Haughian CR; Abbass-Dick J
    BMJ Open; 2019 May; 9(5):e025606. PubMed ID: 31129579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Older Patient and Caregiver Perspectives on Medication Value and Deprescribing: A Qualitative Study.
    Pickering AN; Hamm ME; Dawdani A; Hanlon JT; Thorpe CT; Gellad WF; Radomski TR
    J Am Geriatr Soc; 2020 Apr; 68(4):746-753. PubMed ID: 32067226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines.
    Farrell B; Richardson L; Raman-Wilms L; de Launay D; Alsabbagh MW; Conklin J
    Res Social Adm Pharm; 2018 Jan; 14(1):18-25. PubMed ID: 28214150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. General practitioners and management of chronic noncancer pain: a cross-sectional survey of influences on opioid deprescribing.
    White R; Hayes C; Boyes AW; Chiu S; Paul CL
    J Pain Res; 2019; 12():467-475. PubMed ID: 30774416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deprescribing Opioids in Chronic Non-cancer Pain: Systematic Review of Randomised Trials.
    Mathieson S; Maher CG; Ferreira GE; Hamilton M; Jansen J; McLachlan AJ; Underwood M; Lin CC
    Drugs; 2020 Oct; 80(15):1563-1576. PubMed ID: 32737739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health professionals' and researchers' opinions on conducting clinical deprescribing trials.
    Clough AJ; Hilmer SN; Kouladjian-O'Donnell L; Naismith SL; Gnjidic D
    Pharmacol Res Perspect; 2019 Jun; 7(3):e00476. PubMed ID: 31049205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deprescribing: An educational imperative.
    Raman-Wilms L; Farrell B; Sadowski C; Austin Z
    Res Social Adm Pharm; 2019 Jun; 15(6):790-795. PubMed ID: 30241871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring deprescribing opportunities for community pharmacists using the Behaviour Change Wheel.
    Korenvain C; MacKeigan LD; Dainty KN; Guilcher SJT; McCarthy LM
    Res Social Adm Pharm; 2020 Dec; 16(12):1746-1753. PubMed ID: 32094042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.